-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C6ePvQgCTAz/qgWjN1YQIjy3/+JNkmxb6UpW1TFLPO4dimfWPlp+WmbWpQ+wzbJz i4pYL7SDCAAsf1JtjJuUAQ== 0000950136-98-002311.txt : 19981211 0000950136-98-002311.hdr.sgml : 19981211 ACCESSION NUMBER: 0000950136-98-002311 CONFORMED SUBMISSION TYPE: SC 14D1/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19981210 GROUP MEMBERS: MAXXIM MEDICAL INC GROUP MEMBERS: MAXXIM MEDICAL, INC. GROUP MEMBERS: MMI ACQUISITION CORP. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CIRCON CORP CENTRAL INDEX KEY: 0000719727 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 953079904 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 14D1/A SEC ACT: SEC FILE NUMBER: 005-36096 FILM NUMBER: 98766837 BUSINESS ADDRESS: STREET 1: 6500 HOLLISTER AVE CITY: SANTA BARBARA STATE: CA ZIP: 93111 BUSINESS PHONE: 8059670404 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MAXXIM MEDICAL INC CENTRAL INDEX KEY: 0000858660 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 760291634 STATE OF INCORPORATION: TX FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: SC 14D1/A BUSINESS ADDRESS: STREET 1: 10300 49TH ST N CITY: CLEARWATER STATE: FL ZIP: 33762 BUSINESS PHONE: 7132405588 MAIL ADDRESS: STREET 1: 10300 49TH STREET NORTH CITY: CLEARWATER STATE: FL ZIP: 33762 SC 14D1/A 1 AMENDED SCHEDULE 14D-1 =============================================================================== SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 -------------- SCHEDULE 14D-1 (AMENDMENT NO. 1) TENDER OFFER STATEMENT PURSUANT TO SECTION 14(D)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 -------------- CIRCON CORPORATION (NAME OF SUBJECT COMPANY) MMI ACQUISITION CORP. MAXXIM MEDICAL, INC. MAXXIM MEDICAL, INC. (BIDDERS) COMMON STOCK, PAR VALUE $0.01 PER SHARE (TITLE OF CLASS OF SECURITIES) 172736 10 0 (CUSIP NUMBER OF CLASS OF SECURITIES) -------------- KENNETH W. DAVIDSON PRESIDENT AND CHIEF EXECUTIVE OFFICER MAXXIM MEDICAL, INC. 10300 49TH STREET NORTH CLEARWATER, FL 33762 TELEPHONE: (727) 561-2100 FACSIMILE: (727) 561-2170 (NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE NOTICES AND COMMUNICATIONS ON BEHALF OF BIDDERS) COPY TO: MICHAEL E. GIZANG, ESQ. SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP 919 THIRD AVENUE NEW YORK, NY 10022 TELEPHONE: (212) 735-3000 FACSIMILE: (212) 735-2000 -------------- CALCULATION OF FILING FEE =============================================================================== TRANSACTION VALUATION* $219,797,445 AMOUNT OF FILING FEE $43,960 =============================================================================== * Estimated for purposes of calculating the amount of the filing fee only. This amount assumes the purchase of 14,653,163 shares of common stock, $0.01 par value per share (the "Shares"), of Circon Corporation at a price of $15.00 per Share in cash, without interest thereon. Such number of Shares represents the 13,440,490 Shares outstanding as of November 20, 1998, and assumes the issuance prior to the consummation of the Offer of 1,212,673 Shares upon the exercise or conversion of outstanding stock options and warrants. The amount of the filing fee calculated in accordance with Regulation 240.0-11 of the Securities Exchange Act of 1934, as amended, equals 1/50th of one percent of the value of the transaction. [X] Check box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. Amount Previously Paid: $43,960 Form or Registration No.: Schedule 14D-1 Filing Party: Maxxim Medical, Inc., Maxxim Medical, Inc. and MMI Acquisition Corp. Date Filed: November 30, 1998 =============================================================================== 14D-1 - --------------------- CUSIP NO. 172736 10 0 - --------------------- - ------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS MMI ACQUISITION CORP. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK - ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(e) OR 2(f) [ ] - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - ------------------------------------------------------------------------------- 7 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON NONE - ------------------------------------------------------------------------------- 8 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES CERTAIN SHARES [ ] - ------------------------------------------------------------------------------- 9 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7) - ------------------------------------------------------------------------------- 10 TYPE OF REPORTING PERSON CO - ------------------------------------------------------------------------------- 2 14D-1 - --------------------- CUSIP NO. 172736 10 1 - --------------------- - ------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS MAXXIM MEDICAL, INC. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK - ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(e) OR 2(f) [ ] - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - ------------------------------------------------------------------------------- 7 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON NONE - ------------------------------------------------------------------------------- 8 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES CERTAIN SHARES [ ] - ------------------------------------------------------------------------------- 9 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7) - ------------------------------------------------------------------------------- 10 TYPE OF REPORTING PERSON CO - ------------------------------------------------------------------------------- 3 14D-1 - --------------------- CUSIP NO. 172736 10 1 - --------------------- - ------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS MAXXIM MEDICAL, INC. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK - ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(e) OR 2(f) [ ] - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION TEXAS - ------------------------------------------------------------------------------- 7 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON NONE - ------------------------------------------------------------------------------- 8. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES CERTAIN SHARES [ ] - ------------------------------------------------------------------------------- 9 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7) - ------------------------------------------------------------------------------- 10 TYPE OF REPORTING PERSON CO - ------------------------------------------------------------------------------- 4 TENDER OFFER This Amendment No. 1 amends and supplements the Tender Offer Statement on Schedule 14D-1 filed on November 30, 1998 (as amended and supplemented, the "Statement"), relating to the offer by MMI Acquisition Corp., a Delaware corporation ("Purchaser"), and a wholly owned subsidiary of Maxxim Medical, Inc., a Delaware corporation ("Parent"), a wholly owned subsidiary of Maxxim Medical, Inc., a Texas corporation ("Maxxim"), to purchase all of the outstanding shares of common stock, par value $0.01 per share (the "Common Stock"), including the associated preferred stock purchase rights issued pursuant to the Rights Agreement, dated as of August 14, 1996, by and between the Company and Chase Mellon Shareholder Services, LLC, as Rights Agent (the "Rights" and, together with the Common Stock, the `Shares"), of Circon Corporation, a Delaware corporation (the "Company"), at $15.00 per Share, net to the seller in cash, without interest thereon, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated November 30, 1998, and the related Letter of Transmittal. Unless otherwise indicated, the capitalized terms used herein shall have the meanings specified in the Statement, including the Offer to Purchase previously filed as Exhibit (a)(1) thereto. ITEM 10. ADDITIONAL INFORMATION. On December 10, 1998, Maxxim issued a press release announcing that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, relating to the Offer had expired. The full text of the press release is attached hereto as Exhibit (a)(10). ITEM 11. MATERIALS TO BE FILED AS EXHIBITS. (a)(1) Offer to Purchase, dated November 30, 1998.* (a)(2) Letter of Transmittal.* (a)(3) Notice of Guaranteed Delivery.* (a)(4) Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.* (a)(5) Letter to Clients for use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.* (a)(6) Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9.* (a)(7) Press Release, dated November 21, 1998.* (a)(8) Press Release, dated November 30, 1998.* (a)(9) Summary Advertisement.* (a)(10) Press Release, dated December 10, 1998. (b)(1) Commitment Letter, dated as of November 21, 1998, by and among Maxxim, NationsBank, N.A. and NationsBanc Montgomery Securities LLC.* (c)(1) Agreement and Plan of Merger, dated as of November 21, 1998, by and among Parent, Purchaser and the Company.* (c)(2) Exclusivity Agreement, dated as of November 17, 1998, by and between Maxxim and the Company.* (d) None. (e) Not applicable. (f) None. - ---------- * Previously filed. 5 SIGNATURE After due inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: December 10, 1998 MMI ACQUISITION CORP. By: /s/ KENNETH W. DAVIDSON ------------------------------------ Name: Kenneth W. Davidson Title: President MAXXIM MEDICAL, INC. By: /s/ KENNETH W. DAVIDSON ------------------------------------ Name: Kenneth W. Davidson Title: Chairman of the Board, President and Chief Executive Officer MAXXIM MEDICAL, INC. By: /s/ KENNETH W. DAVIDSON ------------------------------------ Name: Kenneth W. Davidson Title: Chairman of the Board, President and Chief Executive Officer INDEX TO EXHIBITS
SEQUENTIAL EXHIBIT PAGE NO. - --------------- ----------- (a)(1) Offer to Purchase, dated November 30, 1998.* (a)(2) Letter of Transmittal.* (a)(3) Notice of Guaranteed Delivery.* (a)(4) Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.* (a)(5) Letter to Clients for use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.* (a)(6) Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9.* (a)(7) Press Release, dated November 21, 1998.* (a)(8) Press Release, dated November 30, 1998.* (a)(9) Summary Advertisement.* (a)(10) Press Release, dated December 10, 1998. (b)(1) Commitment Letter, dated as of November 21, 1998, by and among Maxxim, NationsBank, N.A. and NationsBanc Montgomery Securities LLC.* (c)(1) Agreement and Plan of Merger, dated as of November 21, 1998, by and among Parent, Purchaser and the Company.* (c)(2) Exclusivity Agreement, dated as of November 17, 1998, by and between Maxxim and the Company.* (d) None. (e) Not applicable. (f) None.
- ---------- * Previously filed. EX-99.(A)(10) 2 PRESS RELEASE Exhibit (a)(10) FOR: MAXXIM MEDICAL, INC. APPROVED BY: Peter M. Graham Executive Vice President 727/561-2100 CONTACTS: Mary Lugris Investor Relations 727/561-2100 Morgen-Walke Associates Andrea Kaimowitz/Katherine Mittelbusher Press: Darren Brandt 212/850-5600 FOR IMMEDIATE RELEASE MAXXIM MEDICAL ANNOUNCES EXPIRATION OF HART-SCOTT-RODINO WAITING PERIOD REGARDING PENDING ACQUISITION OF CIRCON CORPORATION CLEARWATER, FLORIDA, DECEMBER 10, 1998 -- MAXXIM MEDICAL, INC. (NYSE: MAM) announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, applicable to the pending acquisition of Circon Corporation (Nasdaq: CCON) expired at 11:59 p.m., on December 9, 1998. Maxxim Medical, Inc., its wholly owned subsidiary, MMI Acquisition Corp. and Circon Corporation executed a merger agreement on November 21, 1998, pursuant to which MMI Acquisition Corp. commenced on November 30, 1998, a cash tender offer to purchase all of the outstanding shares of Circon Corporation at a price of $15.00 per share. The offer is subject to certain conditions, including among other things, the tender of at least a majority of the shares of Circon outstanding on a fully diluted basis. The offer and withdrawal rights are scheduled to expire at 5:00 p.m., New York City time, on Tuesday, January 5, 1999, unless the offer is extended. Maxxim Medical is a major, diversified manufacturer, distributor and marketer of disposable specialty medical products such as custom procedure trays, medical gloves, electrosurgical systems and disposable products for use in cardiology, radiology and critical care. Maxxim has annual revenues in excess of $500 million. This press release is neither an offer to purchase nor a solicitation of an offer to sell securities. The tender offer is made only through the Offer to Purchase and the related Letter of Transmittal which were distributed on or about November 30, 1998 to stockholders. Additional copies of such documents can be obtained by contacting, MacKenzie Partners, Inc., the Information Agent, at (212) 929-5500 (collect) or call toll free at (800) 322-2885. ### -----END PRIVACY-ENHANCED MESSAGE-----